Page last updated: 2024-10-29

imipramine and Experimental Mammary Neoplasms

imipramine has been researched along with Experimental Mammary Neoplasms in 2 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gurrapu, S1
Jonnalagadda, SK1
Alam, MA1
Ronayne, CT1
Nelson, GL1
Solano, LN1
Lueth, EA1
Drewes, LR1
Mereddy, VR1
Pradhan, SN1
Ray, P1

Other Studies

2 other studies available for imipramine and Experimental Mammary Neoplasms

ArticleYear
Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents.
    Bioorganic & medicinal chemistry letters, 2016, 07-15, Volume: 26, Issue:14

    Topics: Animals; Antineoplastic Agents; Carboxylic Acids; Cell Line, Tumor; Cell Proliferation; Coumarins; D

2016
Effects of stress on growth of transplanted and 7,12-dimethylbenz(alpha)anthracene-induced tumors and their modification by psychotropic drugs.
    Journal of the National Cancer Institute, 1974, Volume: 53, Issue:5

    Topics: Adrenal Glands; Animals; Benz(a)Anthracenes; Body Weight; Chlorpromazine; Electroshock; Female; Huma

1974